Bristol-Myers Squibb swallows last of antibody pioneers

被引：0

|

作者：

Malorye Allison

机构：

来源：

Nature Biotechnology | 2009年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：781 / 783

页数：2

相关论文

共 50 条

[21] Bristol-Myers Squibb clarification on didanosine supply
Pasqualone, Frank
LANCET, 2010, 376 (9746): : 1054 - 1054
[22] BRISTOL-MYERS SQUIBB FINED IN PLAVIX DISPUTE
不详
CHEMICAL & ENGINEERING NEWS, 2009, 87 (14) : 22 - 22
[23] AstraZeneca (Sweden)/Bristol-Myers Squibb (UK)
不详
JOURNAL OF DIABETES, 2009, 1 (04) : 232 - 233
[24] BRISTOL-MYERS SQUIBB BUILDS BIOLOGICS PLANT
不详
CHEMICAL & ENGINEERING NEWS, 2014, 92 (47) : 14 - 14
[25] The patient labeling program at Bristol-Myers Squibb
O'Connell, CA
Skinner, R
DRUG INFORMATION JOURNAL, 1999, 33 (03): : 649 - 654
[26] Bristol-Myers Squibb to buy tech center
不详
CHEMICAL & ENGINEERING NEWS, 1997, 75 (26) : 20 - 20
[27] Technology evaluation: Abatacept, bristol-myers squibb
Dumont, FJ
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (03) : 318 - 330
[28] Bristol-Myers Squibb rapped over generics
不详
CHEMISTRY & INDUSTRY, 2003, (06) : 7 - 7
[29] Bristol-Myers Squibb invests in cancer antibody that targets the innate immune system
Nature Reviews Drug Discovery, 2011, 10 : 648 - 648
[30] Technology evaluation: Belatacept, Bristol-Myers Squibb
Vanhove, B
Soulillou, JP
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (04) : 384 - 393

← 1 2 3 4 5 →